Audit Avoidance Guide for Listed Companies: High-Frequency Travel Expense Risks and Rectification

The article highlights that travel expense reimbursement is a key audit focus for listed companies. Common risks include incomplete evidence chains, split reimbursements, post-hoc approval of over-limit expenses, fraudulent claims, non-compliant invoices, unsupported cross-entity allocations, poor subsidy management, and difficult overseas documentation. Root causes are post-hoc controls and system silos. It recommends native integrated platforms for pre-trip controls and unified data, citing cases like Zhiyu Zhilian and Changbaishan Pharmaceutical.